Sarcoidosis is a relatively rare disease, but its prevalence varies across different populations and regions. It is estimated that approximately 10 to 40 cases per 100,000 people are diagnosed with sarcoidosis each year. However, it is important to note that these numbers may not accurately reflect the true prevalence, as many cases go undiagnosed or misdiagnosed due to the disease's diverse symptoms and lack of specific diagnostic tests.
Sarcoidosis can affect individuals of any age, gender, or ethnicity, but it is more commonly diagnosed in adults between the ages of 20 and 40. The disease also exhibits geographical variations, with higher prevalence reported in certain regions such as Scandinavia, Northern Europe, and parts of the United States.
While sarcoidosis is not considered a common condition, its impact on individuals can be significant. The disease primarily affects the lungs, but it can also involve other organs such as the skin, eyes, heart, and nervous system. Early diagnosis and appropriate treatment are crucial in managing the symptoms and preventing long-term complications associated with sarcoidosis.